NCT06728319View on ClinicalTrials.gov

A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World

Active, not recruitingOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

September 19, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Lung Nodules
Trial Locations (5)

15801

The Lung Center, PC, DuBois

32548

White-Wilson Medical Center, Fort Walton Beach

33511

Pulmonary & Sleep of Tampa Bay, Brandon

42503

The Lung and Sleep Disorder Institute, Somerset

02720

Southcoast Health System, Fairhaven

Sponsors

Lead Sponsor

Biodesix, Inc.
All Listed Sponsors
lead

Biodesix, Inc.

INDUSTRY

NCT06728319 - A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World | Biotech Hunter | Biotech Hunter